MetaADEDB 2.0 @ LMMD
Methylphenidate
(JUMYIBMBTDDLNG-UHFFFAOYSA-N)
Structure
SMILES
COC(=O)C(c1ccccc1)C1CCCCN1.Cl
Molecular Formula:
C14H20ClNO2
Molecular Weight:
269.767
Log P:
3.2161
Hydrogen Bond Acceptor:
3
Hydrogen Bond Donor:
2
TPSA:
38.33
CAS Number(s):
113-45-1; 298-59-9
Synonym(s)
1.
Methylphenidate
2.
Centedrin
3.
Concerta
4.
Daytrana
5.
Equasym
6.
Metadate
7.
Methylin
8.
Methylphenidate Hydrochloride
9.
Phenidylate
10.
Ritalin
11.
Ritalin-SR
12.
Ritaline
13.
Tsentedrin
14.
Hydrochloride, Methylphenidate
15.
Ritalin SR
External Link(s)
MeSHD008774
PubChem Compound57516065
9280
10945497
ChEBI31836
CHEMBLCHEMBL1722
KEGGdr:D01296
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1Drug ineffectiveFAERS: 711
Canada Vigilance: 61
Canada Vigilance
US FAERS
2HeadacheFAERS: 169
Canada Vigilance: 5
Canada Vigilance
US FAERS
3AgitationFAERS: 161
Canada Vigilance: 4
Canada Vigilance
US FAERS
4AnxietyFAERS: 148
Canada Vigilance: 1
Canada Vigilance
US FAERS
5Feeling abnormalFAERS: 132US FAERS
6Drug effect incompleteFAERS: 121US FAERS
7NauseaFAERS: 118
Canada Vigilance: 3
Canada Vigilance
US FAERS
8VomitingFAERS: 110US FAERS
9Product use issueFAERS: 109US FAERS
10Toxicity to various agentsFAERS: 99US FAERS
11Product substitution issueFAERS: 88US FAERS
12SomnolenceFAERS: 88
Canada Vigilance: 2
Canada Vigilance
US FAERS
13TachycardiaFAERS: 84US FAERS
14MalaiseFAERS: 82
Canada Vigilance: 1
Canada Vigilance
US FAERS
15Product quality issueFAERS: 77
Canada Vigilance: 5
Canada Vigilance
US FAERS
16CryingFAERS: 74
Canada Vigilance: 2
Canada Vigilance
US FAERS
17FatigueFAERS: 74US FAERS
18AngerFAERS: 73US FAERS
19Drug abuseFAERS: 69
Canada Vigilance: 1
Canada Vigilance
US FAERS
20Drug dose omissionFAERS: 69US FAERS
21Myocardial InfarctionFAERS: 68US FAERS
22Cerebrovascular accidentFAERS: 66US FAERS
23Weight decreasedFAERS: 65
Canada Vigilance: 2
Canada Vigilance
US FAERS
24DizzinessFAERS: 64
Canada Vigilance: 1
Canada Vigilance
US FAERS
25PalpitationsFAERS: 57US FAERS
26Product taste abnormalFAERS: 57US FAERS
27TremorFAERS: 54US FAERS
28Emotional disorderFAERS: 52US FAERS
29Drug DependenceFAERS: 51US FAERS
30OverdoseFAERS: 47US FAERS
31Poor quality drug administeredFAERS: 43US FAERS
32Suicide attemptFAERS: 43US FAERS
33RestlessnessFAERS: 40
Canada Vigilance: 1
Canada Vigilance
US FAERS
34Abdominal PainFAERS: 39
Canada Vigilance: 4
Canada Vigilance
US FAERS
35Intentional product misuseFAERS: 39US FAERS
36Drug administered to patient of inappropriate ageFAERS: 38US FAERS
37Pharmaceutical product complaintFAERS: 38US FAERS
38Incorrect dose administeredFAERS: 36US FAERS
39Depressed moodFAERS: 35US FAERS
40Sudden deathFAERS: 35US FAERS
41DysgeusiaFAERS: 33US FAERS
42NervousnessFAERS: 33US FAERS
43Drug dispensing errorFAERS: 31US FAERS
44MydriasisFAERS: 31US FAERS
45Chest PainFAERS: 30
Canada Vigilance: 1
Canada Vigilance
US FAERS
46Educational problemFAERS: 29US FAERS
47HypersensitivityFAERS: 29US FAERS
48SyncopeFAERS: 29
Canada Vigilance: 1
Canada Vigilance
US FAERS
49Wrong technique in product usage processFAERS: 28US FAERS
50Abdominal discomfortFAERS: 27US FAERS
51Adverse eventFAERS: 27US FAERS
52Mood swingsFAERS: 26US FAERS
53ApathyFAERS: 25US FAERS
54LethargyFAERS: 24US FAERS
55PainFAERS: 24
Canada Vigilance: 1
Canada Vigilance
US FAERS
56Euphoric moodFAERS: 23
Canada Vigilance: 1
Canada Vigilance
US FAERS
57RetchingFAERS: 23US FAERS
58Therapeutic response unexpected with drug substitutionFAERS: 23US FAERS
59Incorrect route of drug administrationFAERS: 22US FAERS
60Product dose omissionFAERS: 22US FAERS
61Growth retardationFAERS: 21US FAERS
62Wrong technique in drug usage processFAERS: 21US FAERS
63AstheniaFAERS: 20US FAERS
64Intentional drug misuseFAERS: 20US FAERS
65PruritusFAERS: 18US FAERS
66DystoniaFAERS: 17US FAERS
67Memory impairmentFAERS: 17US FAERS
68ParanoiaFAERS: 17
Canada Vigilance: 1
Canada Vigilance
US FAERS
69Personality ChangeFAERS: 17US FAERS
70StressFAERS: 16US FAERS
71Activities of daily living impairedFAERS: 15US FAERS
72Drug withdrawal syndromeFAERS: 15US FAERS
73Product use in unapproved indicationFAERS: 15US FAERS
74AmnesiaFAERS: 14US FAERS
75DisorientationFAERS: 14
Canada Vigilance: 4
Canada Vigilance
US FAERS
76Feeling jitteryFAERS: 14US FAERS
77Intentional product use issueFAERS: 14US FAERS
78Product physical issueFAERS: 14US FAERS
79UrticariaFAERS: 14
Canada Vigilance: 1
Canada Vigilance
US FAERS
80Blood creatine phosphokinase increasedFAERS: 13US FAERS
81Drug prescribing errorFAERS: 13US FAERS
82Inappropriate schedule of drug administrationFAERS: 13US FAERS
83Intentional self-injuryFAERS: 13US FAERS
84Loss of personal independence in daily activitiesFAERS: 13US FAERS
85Medication ErrorFAERS: 13
Canada Vigilance: 1
Canada Vigilance
US FAERS
86Therapeutic response unexpectedFAERS: 13US FAERS
87ArthralgiaFAERS: 12US FAERS
88AsthmaFAERS: 12US FAERS
89Cardiac ArrestFAERS: 12US FAERS
90DeafnessFAERS: 12US FAERS
91DysarthriaFAERS: 12US FAERS
92ErythemaFAERS: 12US FAERS
93Obsessive-Compulsive DisorderFAERS: 12US FAERS
94Performance status decreasedFAERS: 12US FAERS
95Rebound effectFAERS: 12US FAERS
96AlopeciaFAERS: 11US FAERS
97ConstipationFAERS: 11
Canada Vigilance: 1
Canada Vigilance
US FAERS
98Drug diversionFAERS: 11US FAERS
99Drug ineffective for unapproved indicationFAERS: 11US FAERS
100Initial insomniaFAERS: 11US FAERS
101nervous system disorderFAERS: 11US FAERS
102Bipolar DisorderFAERS: 10US FAERS
103Emotional distressFAERS: 10US FAERS
104Excessive eye blinkingFAERS: 10US FAERS
105Inappropriate schedule of product administrationFAERS: 10US FAERS
106Incorrect product storageFAERS: 10US FAERS
107NeutropeniaFAERS: 10US FAERS
108Psychiatric symptomFAERS: 10US FAERS
109ScreamingFAERS: 10US FAERS
110TrismusFAERS: 10US FAERS
111Visual ImpairmentFAERS: 10US FAERS
112Accidental exposure to product by childFAERS: 9US FAERS
113Acute myocardial infarctionFAERS: 9US FAERS
114Chest discomfortFAERS: 9US FAERS
115DeliriumFAERS: 9US FAERS
116Depressed Level of ConsciousnessFAERS: 9US FAERS
117Drug screen negativeFAERS: 9US FAERS
118FlushingFAERS: 9US FAERS
119MyalgiaFAERS: 9US FAERS
120NasopharyngitisFAERS: 9US FAERS
121SinusitisFAERS: 9US FAERS
122TrichotillomaniaFAERS: 9US FAERS
123UnderweightFAERS: 9US FAERS
124VertigoFAERS: 9
Canada Vigilance: 1
Canada Vigilance
US FAERS
125Accidental exposure to productFAERS: 8US FAERS
126Alanine Aminotransferase IncreasedFAERS: 8US FAERS
127CataractFAERS: 8US FAERS
128Completed SuicideFAERS: 8US FAERS
129DiscomfortFAERS: 8US FAERS
130HungerFAERS: 8US FAERS
131Neck PainFAERS: 8US FAERS
132Sinus TachycardiaFAERS: 8US FAERS
133StaringFAERS: 8US FAERS
134TinnitusFAERS: 8US FAERS
135Cerebral InfarctionFAERS: 7US FAERS
136Drug screen positiveFAERS: 7US FAERS
137EpistaxisFAERS: 7US FAERS
138Expired product administeredFAERS: 7US FAERS
139Fight in schoolFAERS: 7US FAERS
140FormicationFAERS: 7US FAERS
141InfluenzaFAERS: 7US FAERS
142Mastication disorderFAERS: 7US FAERS
143PallorFAERS: 7
Canada Vigilance: 1
Canada Vigilance
US FAERS
144SwellingFAERS: 7US FAERS
145Therapeutic response changedFAERS: 7US FAERS
146Throat irritationFAERS: 7US FAERS
147Unevaluable eventFAERS: 7US FAERS
148WheezingFAERS: 7US FAERS
149Accidental overdoseFAERS: 6US FAERS
150AnorexiaFAERS: 6US FAERS
151Aspartate Aminotransferase IncreasedFAERS: 6US FAERS
152Circumstance or information capable of leading to medication errorFAERS: 6US FAERS
153DiplopiaFAERS: 6US FAERS
154Drug administration errorFAERS: 6US FAERS
155Drug effect variableFAERS: 6US FAERS
156Drug exposure during pregnancyFAERS: 6US FAERS
157DysphemiaFAERS: 6US FAERS
158Electrocardiogram abnormalFAERS: 6US FAERS
159Frustration tolerance decreasedFAERS: 6US FAERS
160Gastrointestinal PainFAERS: 6US FAERS
161HypersomniaFAERS: 6US FAERS
162Impaired work abilityFAERS: 6
Canada Vigilance: 1
Canada Vigilance
US FAERS
163Musculoskeletal stiffnessFAERS: 6US FAERS
164Prescribed overdoseFAERS: 6US FAERS
165PriapismFAERS: 6US FAERS
166Product packaging quantity issueFAERS: 6US FAERS
167Product preparation errorFAERS: 6US FAERS
168AbasiaFAERS: 5US FAERS
169Altered state of consciousnessFAERS: 5US FAERS
170Amphetamines positiveFAERS: 5US FAERS
171AphasiaFAERS: 5US FAERS
172CyanosisFAERS: 5US FAERS
173DysphoniaFAERS: 5US FAERS
174EpilepsyFAERS: 5US FAERS
175Erectile dysfunctionFAERS: 5US FAERS
176Erection increasedFAERS: 5US FAERS
177Extremity necrosisFAERS: 5US FAERS
178Feeling ColdFAERS: 5US FAERS
179FractureFAERS: 5US FAERS
180General physical health deteriorationFAERS: 5US FAERS
181HyperphagiaFAERS: 5US FAERS
182Impaired driving abilityFAERS: 5US FAERS
183Liquid product physical issueFAERS: 5US FAERS
184Maternal exposure during pregnancyFAERS: 5US FAERS
185Medication residue presentFAERS: 5US FAERS
186Mental impairmentFAERS: 5US FAERS
187MoroseFAERS: 5US FAERS
188Muscle RigidityFAERS: 5US FAERS
189Product container issueFAERS: 5US FAERS
190Product formulation issueFAERS: 5US FAERS
191Product physical consistency issueFAERS: 5US FAERS
192Product storage errorFAERS: 5US FAERS
193Reaction to drug excipientsFAERS: 5US FAERS
194StrabismusFAERS: 5US FAERS
195Therapeutic product effect incompleteFAERS: 5US FAERS
196Urinary IncontinenceFAERS: 5US FAERS
197Urinary tract infectionFAERS: 5US FAERS
198Ventricular FibrillationFAERS: 5US FAERS
199Accidental exposureFAERS: 4US FAERS
200AngioedemaFAERS: 4US FAERS
201Blood glucose increasedFAERS: 4US FAERS
202BradycardiaFAERS: 4US FAERS
203BruxismFAERS: 4US FAERS
204Burning sensationFAERS: 4US FAERS
205Cardiac enzymes increasedFAERS: 4US FAERS
206Cerebral disorderFAERS: 4US FAERS
207ChoreoathetosisFAERS: 4US FAERS
208Drug abuserFAERS: 4US FAERS
209Drug effect delayedFAERS: 4US FAERS
210DyspepsiaFAERS: 4US FAERS
211EnuresisFAERS: 4US FAERS
212Eye painFAERS: 4US FAERS
213Gingival RecessionFAERS: 4US FAERS
214GlaucomaFAERS: 4US FAERS
215Hallucinations, mixedFAERS: 4US FAERS
216Head discomfortFAERS: 4US FAERS
217HydrocephalusFAERS: 4US FAERS
218HypophagiaFAERS: 4US FAERS
219HyporeflexiaFAERS: 4US FAERS
220HypotensionFAERS: 4US FAERS
221HypothyroidismFAERS: 4US FAERS
222Intercepted drug dispensing errorFAERS: 4US FAERS
223No adverse eventFAERS: 4US FAERS
224Oppositional Defiant DisorderFAERS: 4US FAERS
225Panic DisorderFAERS: 4US FAERS
226Poor quality sleepFAERS: 4US FAERS
227Pre-existing condition improvedFAERS: 4US FAERS
228PresyncopeFAERS: 4US FAERS
229Product use complaintFAERS: 4US FAERS
230SchizophreniaFAERS: 4US FAERS
231ThrombocytopeniaFAERS: 4US FAERS
232Ventricular arrhythmiaFAERS: 4US FAERS
233Violence-related symptomFAERS: 4US FAERS
234jaundiceFAERS: 4US FAERS
235AkathisiaFAERS: 3US FAERS
236Angina PectorisFAERS: 3US FAERS
237ArthritisFAERS: 3US FAERS
238AtaxiaFAERS: 3US FAERS
239BlindnessFAERS: 3US FAERS
240Blood creatinine increasedFAERS: 3US FAERS
241Cerebral artery stenosisFAERS: 3US FAERS
242Cold sweatFAERS: 3US FAERS
243DehydrationFAERS: 3US FAERS
244Dengue FeverFAERS: 3US FAERS
245DependenceFAERS: 3US FAERS
246Diabetes MellitusFAERS: 3US FAERS
247Disease ProgressionFAERS: 3US FAERS
248DissociationFAERS: 3US FAERS
249Drug ToleranceFAERS: 3US FAERS
250Drug level decreasedFAERS: 3US FAERS
251Drug screen false positiveFAERS: 3US FAERS
252DysgraphiaFAERS: 3US FAERS
253DyslexiaFAERS: 3US FAERS
254DysuriaFAERS: 3US FAERS
255Ear discomfortFAERS: 3US FAERS
256EcchymosisFAERS: 3US FAERS
257Electromechanical dissociationFAERS: 3US FAERS
258EructationFAERS: 3US FAERS
259HemiparesisFAERS: 3US FAERS
260HyperkinesiaFAERS: 3US FAERS
261HyperreflexiaFAERS: 3US FAERS
262HyperventilationFAERS: 3US FAERS
263HypomaniaFAERS: 3US FAERS
264ImpatienceFAERS: 3US FAERS
265LacerationFAERS: 3US FAERS
266LeukocytosisFAERS: 3US FAERS
267Limb discomfortFAERS: 3US FAERS
268Limb injuryFAERS: 3US FAERS
269Lip swellingFAERS: 3US FAERS
270Livedo ReticularisFAERS: 3US FAERS
271Mental status changesFAERS: 3US FAERS
272Motion SicknessFAERS: 3US FAERS
273MyocarditisFAERS: 3US FAERS
274NarcolepsyFAERS: 3US FAERS
275NephrolithiasisFAERS: 3US FAERS
276ObesityFAERS: 3US FAERS
277Oropharyngeal painFAERS: 3US FAERS
278ParasomniaFAERS: 3US FAERS
279Physical assaultFAERS: 3US FAERS
280PneumoniaFAERS: 3US FAERS
281PoisoningFAERS: 3US FAERS
282Product contamination physicalFAERS: 3US FAERS
283Product measured potency issueFAERS: 3US FAERS
284Product packaging issueFAERS: 3US FAERS
285Product size issueFAERS: 3US FAERS
286Pulmonary EmbolismFAERS: 3US FAERS
287Renal tubular acidosisFAERS: 3US FAERS
288Respiratory arrestFAERS: 3US FAERS
289RhabdomyolysisFAERS: 3US FAERS
290TachyphreniaFAERS: 3US FAERS
291Tardive DyskinesiaFAERS: 3US FAERS
292TensionFAERS: 3US FAERS
293ThirstFAERS: 3US FAERS
294TonsillectomyFAERS: 3US FAERS
295TorticollisFAERS: 3US FAERS
296Transaminases increasedFAERS: 3US FAERS
297Unresponsive to stimuliFAERS: 3US FAERS
298Urinary RetentionFAERS: 3US FAERS
299Ventricular DysfunctionFAERS: 3US FAERS
300Visual disturbanceFAERS: 3US FAERS
301Vitreous floatersFAERS: 3US FAERS
302AbscessFAERS: 2US FAERS
303Accidental drug intake by childFAERS: 2US FAERS
304AgeusiaFAERS: 2US FAERS
305Ankle FractureFAERS: 2US FAERS
306Anoxic EncephalopathyFAERS: 2US FAERS
307AphagiaFAERS: 2US FAERS
308AphoniaFAERS: 2US FAERS
309AppendicitisFAERS: 2US FAERS
310AsphyxiaFAERS: 2US FAERS
311Back PainFAERS: 2US FAERS
312BelligerenceFAERS: 2US FAERS
313Benign Rolandic EpilepsyFAERS: 2US FAERS
314Blood lactate dehydrogenase increasedFAERS: 2US FAERS
315Blood potassium decreasedFAERS: 2US FAERS
316Blood thyroid stimulating hormone increasedFAERS: 2US FAERS
317Blood urine presentFAERS: 2US FAERS
318Body height below normalFAERS: 2US FAERS
319Bone density decreasedFAERS: 2US FAERS
320Brain stem syndromeFAERS: 2US FAERS
321BronchitisFAERS: 2US FAERS
322CD4 Lymphocytes DecreasedFAERS: 2US FAERS
323Cerebral artery occlusionFAERS: 2US FAERS
324ChokingFAERS: 2US FAERS
325CholestasisFAERS: 2US FAERS
326Concomitant disease aggravatedFAERS: 2US FAERS
327Conduct DisorderFAERS: 2US FAERS
328Decreased immune responsivenessFAERS: 2US FAERS
329Deep Vein ThrombosisFAERS: 2US FAERS
330Disseminated Intravascular CoagulationFAERS: 2US FAERS
331Drug toxicityFAERS: 2US FAERS
332Electrocardiogram changeFAERS: 2US FAERS
333EncephalitisFAERS: 2US FAERS
334EnophthalmosFAERS: 2US FAERS
335Eye inflammationFAERS: 2US FAERS
336Facial ParesisFAERS: 2US FAERS
337FrustrationFAERS: 2US FAERS
338Gait inabilityFAERS: 2US FAERS
339GastroenteritisFAERS: 2US FAERS
340General physical condition abnormalFAERS: 2US FAERS
341Head titubationFAERS: 2US FAERS
342Hepatitis AFAERS: 2US FAERS
343Hepatitis EFAERS: 2US FAERS
344HepatitisFAERS: 2US FAERS
345HepatotoxicityFAERS: 2US FAERS
346HostilityFAERS: 2US FAERS
347Inappropriate affectFAERS: 2US FAERS
348IncontinenceFAERS: 2US FAERS
349InflammationFAERS: 2US FAERS
350Intention tremorFAERS: 2US FAERS
351Intentional dose omissionFAERS: 2US FAERS
352Intentional misuseFAERS: 2US FAERS
353Joint swellingFAERS: 2US FAERS
354LeukopeniaFAERS: 2US FAERS
355Lupus-like syndromeFAERS: 2US FAERS
356MeningitisFAERS: 2US FAERS
357Mental RetardationFAERS: 2US FAERS
358Middle insomniaFAERS: 2US FAERS
359MutismFAERS: 2US FAERS
360MyopathyFAERS: 2US FAERS
361Nail pickingFAERS: 2US FAERS
362Negative thoughtsFAERS: 2US FAERS
363No adverse effectFAERS: 2US FAERS
364Obsessive thoughtsFAERS: 2US FAERS
365Obsessive-compulsive symptomFAERS: 2US FAERS
366PericarditisFAERS: 2US FAERS
367PhotophobiaFAERS: 2US FAERS
368PneumothoraxFAERS: 2US FAERS
369PolydipsiaFAERS: 2US FAERS
370PolyuriaFAERS: 2US FAERS
371Postural Orthostatic Tachycardia SyndromeFAERS: 2US FAERS
372PregnancyFAERS: 2US FAERS
373Product administration errorFAERS: 2US FAERS
374Product availability issueFAERS: 2US FAERS
375Product difficult to swallowFAERS: 2US FAERS
376Product dispensing errorFAERS: 2US FAERS
377Psychotic symptomFAERS: 2US FAERS
378Pulmonary HypertensionFAERS: 2US FAERS
379Pulmonary arterial hypertensionFAERS: 2US FAERS
380PyelonephritisFAERS: 2US FAERS
381QuadriplegiaFAERS: 2US FAERS
382Quality of life decreasedFAERS: 2US FAERS
383Rash erythematousFAERS: 2US FAERS
384Respiratory FailureFAERS: 2US FAERS
385School refusalFAERS: 2US FAERS
386ShockFAERS: 2US FAERS
387Sinus bradycardiaFAERS: 2US FAERS
388SluggishnessFAERS: 2US FAERS
389SneezingFAERS: 2US FAERS
390Suspected counterfeit productFAERS: 2US FAERS
391Sympathomimetic EffectFAERS: 2US FAERS
392TetanyFAERS: 2US FAERS
393Therapy changeFAERS: 2US FAERS
394ThrombosisFAERS: 2US FAERS
395treatment failureFAERS: 2US FAERS
396Accelerated Idioventricular RhythmFAERS: 1US FAERS
397Acne fulminansFAERS: 1US FAERS
398Activated Protein C ResistanceFAERS: 1US FAERS
399Acute Coronary SyndromeFAERS: 1US FAERS
400Acute psychosisFAERS: 1US FAERS
401Acute respiratory failureFAERS: 1US FAERS
402Agitated depressionFAERS: 1US FAERS
403Alopecia universalisFAERS: 1US FAERS
404AmblyopiaFAERS: 1US FAERS
405Amnestic DisorderFAERS: 1US FAERS
406Amylase increasedFAERS: 1US FAERS
407AngioplastyFAERS: 1US FAERS
408Angle Closure GlaucomaFAERS: 1US FAERS
409AnhidrosisFAERS: 1US FAERS
410AnisometropiaFAERS: 1US FAERS
411Aortic AneurysmFAERS: 1US FAERS
412Aortic embolusFAERS: 1US FAERS
413Apallic syndromeFAERS: 1US FAERS
414Application site painFAERS: 1US FAERS
415Arthropod biteFAERS: 1US FAERS
416AstrocytomaFAERS: 1US FAERS
417Atrial FibrillationFAERS: 1US FAERS
418Atrial thrombosisFAERS: 1US FAERS
419Autoimmune thyroiditisFAERS: 1US FAERS
420BedriddenFAERS: 1US FAERS
421Benign NeoplasmFAERS: 1US FAERS
422Bipolar I disorderFAERS: 1US FAERS
423Blood alkaline phosphatase increasedFAERS: 1US FAERS
424Blood blisterFAERS: 1US FAERS
425Blood cholesterol increasedFAERS: 1US FAERS
426Blood count abnormalFAERS: 1US FAERS
427Blood creatine phosphokinase MB increasedFAERS: 1US FAERS
428Blood glucose fluctuationFAERS: 1US FAERS
429Blood growth hormone increasedFAERS: 1US FAERS
430Blood pH decreasedFAERS: 1US FAERS
431Blood pressure fluctuationFAERS: 1US FAERS
432Blood prolactin decreasedFAERS: 1US FAERS
433Blunted affectFAERS: 1US FAERS
434Borderline Personality DisorderFAERS: 1US FAERS
435BradyphreniaFAERS: 1US FAERS
436Brain AbscessFAERS: 1US FAERS
437Breast CystFAERS: 1US FAERS
438Bronchitis mycoplasmalFAERS: 1US FAERS
439BronchospasmFAERS: 1US FAERS
440CachexiaFAERS: 1US FAERS
441Capsule physical issueFAERS: 1US FAERS
442Carbon dioxide increasedFAERS: 1US FAERS
443Cardiac discomfortFAERS: 1US FAERS
444CardiomegalyFAERS: 1US FAERS
445CardiotoxicityFAERS: 1US FAERS
446Carpal Tunnel SyndromeFAERS: 1US FAERS
447CatatoniaFAERS: 1US FAERS
448CellulitisFAERS: 1US FAERS
449Cerebellar infarctionFAERS: 1US FAERS
450Cerebral PalsyFAERS: 1US FAERS
451Cerebral arteritisFAERS: 1US FAERS
452Cerebral hypoperfusionFAERS: 1US FAERS
453Change in sustained attentionFAERS: 1US FAERS
454CheilitisFAERS: 1US FAERS
455ChillsFAERS: 1US FAERS
456ChoreaFAERS: 1US FAERS
457ClaustrophobiaFAERS: 1US FAERS
458Cluster HeadacheFAERS: 1US FAERS
459Complications of limb reattachment surgeryFAERS: 1US FAERS
460Consciousness fluctuatingFAERS: 1US FAERS
461Contraindicated product administeredFAERS: 1US FAERS
462Conversion disorderFAERS: 1US FAERS
463CoprolaliaFAERS: 1US FAERS
464Dark circles under eyesFAERS: 1US FAERS
465DementiaFAERS: 1US FAERS
466Dental cariesFAERS: 1US FAERS
467Depression suicidalFAERS: 1US FAERS
468Diastolic dysfunctionFAERS: 1US FAERS
469Diastolic hypertensionFAERS: 1US FAERS
470Diet refusalFAERS: 1US FAERS
471Disruptive mood dysregulation disorderFAERS: 1US FAERS
472Disturbance in sexual arousalFAERS: 1US FAERS
473DiverticulitisFAERS: 1US FAERS
474DroolingFAERS: 1US FAERS
475Drug resistanceFAERS: 1US FAERS
476Duodenal ulcer perforationFAERS: 1US FAERS
477Dural tearFAERS: 1US FAERS
478DysenteryFAERS: 1US FAERS
479Dysthymic DisorderFAERS: 1US FAERS
480Ejection Fraction DecreasedFAERS: 1US FAERS
481Electrocardiogram PQ interval prolongedFAERS: 1US FAERS
482Electrocardiogram T wave peakedFAERS: 1US FAERS
483Electroencephalogram abnormalFAERS: 1US FAERS
484Elevated moodFAERS: 1US FAERS
485Emotional povertyFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
486EosinophiliaFAERS: 1US FAERS
487Epigastric discomfortFAERS: 1US FAERS
488Erythema MultiformeFAERS: 1US FAERS
489Excessive masturbationFAERS: 1US FAERS
490Expired drug administeredFAERS: 1US FAERS
491Exposure via direct contactFAERS: 1US FAERS
492Exposure via skin contactFAERS: 1US FAERS
493Extra dose administeredFAERS: 1US FAERS
494Extranodal marginal zone B-cell lymphoma (MALT type)FAERS: 1US FAERS
495Eye BurnsFAERS: 1US FAERS
496Eye InfectionFAERS: 1US FAERS
497Eye irritationFAERS: 1US FAERS
498Eye symptomFAERS: 1US FAERS
499Eyelid Function DisorderFAERS: 1US FAERS
500Facial paralysisFAERS: 1US FAERS
501Factor V Leiden mutationFAERS: 1US FAERS
502Failure of child resistant mechanism for pharmaceutical productFAERS: 1US FAERS
503Failure to ThriveFAERS: 1US FAERS
504False negative investigation resultFAERS: 1US FAERS
505Female sex hormone level abnormalFAERS: 1US FAERS
506Fibrin D dimer increasedFAERS: 1US FAERS
507FibromyalgiaFAERS: 1US FAERS
508Flat affectFAERS: 1US FAERS
509Fundoscopy abnormalFAERS: 1US FAERS
510Gastric BypassFAERS: 1US FAERS
511Gastroenteritis norovirusFAERS: 1US FAERS
512Gaze palsyFAERS: 1US FAERS
513Genital discomfortFAERS: 1US FAERS
514Gingival erythemaFAERS: 1US FAERS
515Global AmnesiaFAERS: 1US FAERS
516Grip strength decreasedFAERS: 1US FAERS
517Growth failureFAERS: 1US FAERS
518HemiplegiaFAERS: 1US FAERS
519Hepatic congestionFAERS: 1US FAERS
520Hepatic necrosisFAERS: 1US FAERS
521Hepatitis CFAERS: 1US FAERS
522HepatomegalyFAERS: 1US FAERS
523High density lipoprotein increasedFAERS: 1US FAERS
524Histrionic Personality DisorderFAERS: 1US FAERS
525Hormone level abnormalFAERS: 1US FAERS
526HydronephrosisFAERS: 1US FAERS
527HyperacusisFAERS: 1US FAERS
528HypermetabolismFAERS: 1US FAERS
529HyperthyroidismFAERS: 1US FAERS
530Hypertrophic CardiomyopathyFAERS: 1US FAERS
531HypoaldosteronismFAERS: 1US FAERS
532HypokinesiaFAERS: 1US FAERS
533Ideas of referenceFAERS: 1US FAERS
534Idiosyncratic drug reactionFAERS: 1US FAERS
535ImmobileFAERS: 1US FAERS
536Immune thrombocytopenic purpuraFAERS: 1US FAERS
537Implantable defibrillator insertionFAERS: 1US FAERS
538Incorrect drug administration rateFAERS: 1US FAERS
539Incorrect route of product administrationFAERS: 1US FAERS
540Incorrect storage of drugFAERS: 1US FAERS
541Increased bronchial secretionFAERS: 1US FAERS
542InfectionFAERS: 1US FAERS
543Injection site abscessFAERS: 1US FAERS
544Injection site erythemaFAERS: 1US FAERS
545Injection site infectionFAERS: 1US FAERS
546Injection site inflammationFAERS: 1US FAERS
547Injection site necrosisFAERS: 1US FAERS
548Injection site warmthFAERS: 1US FAERS
549Intellectual DisabilityFAERS: 1US FAERS
550Intelligence test abnormalFAERS: 1US FAERS
551Intercepted medication errorFAERS: 1US FAERS
552Intraocular pressure test abnormalFAERS: 1US FAERS
553Investigation abnormalFAERS: 1US FAERS
554IridocyclitisFAERS: 1US FAERS
555Iron deficiencyFAERS: 1US FAERS
556Irritable Bowel SyndromeFAERS: 1US FAERS
557Juvenile arthritisFAERS: 1US FAERS
558Lack of spontaneous speechFAERS: 1US FAERS
559Lactose IntoleranceFAERS: 1US FAERS
560LaryngitisFAERS: 1US FAERS
561LazinessFAERS: 1US FAERS
562Lichen PlanusFAERS: 1US FAERS
563Limb girth decreasedFAERS: 1US FAERS
564Low density lipoprotein abnormalFAERS: 1US FAERS
565Low density lipoprotein increasedFAERS: 1US FAERS
566Lyme DiseaseFAERS: 1US FAERS
567LymphadenopathyFAERS: 1US FAERS
568Lymphoid tissue hyperplasiaFAERS: 1US FAERS
569Lymphomatoid PapulosisFAERS: 1US FAERS
570MacrocephalyFAERS: 1US FAERS
571MalabsorptionFAERS: 1US FAERS
572Manufacturing issueFAERS: 1US FAERS
573MastitisFAERS: 1US FAERS
574MeningiomaFAERS: 1US FAERS
575Metabolic acidosisFAERS: 1US FAERS
576Metanephrine urine increasedFAERS: 1US FAERS
577MicroalbuminuriaFAERS: 1US FAERS
578MicrocephalyFAERS: 1US FAERS
579MicrocytosisFAERS: 1US FAERS
580MonoparesisFAERS: 1US FAERS
581Multiple SclerosisFAERS: 1US FAERS
582Multiple allergiesFAERS: 1US FAERS
583Muscle tightnessFAERS: 1US FAERS
584Musculoskeletal discomfortFAERS: 1US FAERS
585Myoglobin blood increasedFAERS: 1US FAERS
586MyopiaFAERS: 1US FAERS
587Narcissistic Personality DisorderFAERS: 1US FAERS
588Nasal inflammationFAERS: 1US FAERS
589Nasal pruritusFAERS: 1US FAERS
590NegativismFAERS: 1US FAERS
591Nerve injuryFAERS: 1US FAERS
592NocturiaFAERS: 1US FAERS
593Nonspecific reactionFAERS: 1US FAERS
594Normetanephrine urine increasedFAERS: 1US FAERS
595Nuchal RigidityFAERS: 1US FAERS
596Oral candidiasisFAERS: 1US FAERS
597Oral mucosal erythemaFAERS: 1US FAERS
598Oromandibular dystoniaFAERS: 1US FAERS
599Oropharyngeal discomfortFAERS: 1US FAERS
600Orthostatic intoleranceFAERS: 1US FAERS
601PancreatitisFAERS: 1US FAERS
602ParesisFAERS: 1US FAERS
603Patient uncooperativeFAERS: 1US FAERS
604Pericardial effusionFAERS: 1US FAERS
605PertussisFAERS: 1US FAERS
606PolyneuropathyFAERS: 1US FAERS
607Poor peripheral circulationFAERS: 1US FAERS
608PoriomaniaFAERS: 1US FAERS
609Poverty of speechFAERS: 1US FAERS
610Pre-EclampsiaFAERS: 1US FAERS
611Precocious PubertyFAERS: 1US FAERS
612Pressure of speechFAERS: 1US FAERS
613Product closure issueFAERS: 1US FAERS
614Product container seal issueFAERS: 1US FAERS
615Product dosage form issueFAERS: 1US FAERS
616Product label confusionFAERS: 1US FAERS
617Product label issueFAERS: 1US FAERS
618Product label on wrong productFAERS: 1US FAERS
619Product package associated injuryFAERS: 1US FAERS
620Product shape issueFAERS: 1US FAERS
621Product solubility abnormalFAERS: 1US FAERS
622Product tamperingFAERS: 1US FAERS
623Productive CoughFAERS: 1US FAERS
624Progressive supranuclear palsyFAERS: 1US FAERS
625ProlactinomaFAERS: 1US FAERS
626ProteinuriaFAERS: 1US FAERS
627PseudolymphomaFAERS: 1US FAERS
628PsoriasisFAERS: 1US FAERS
629Pulmonary InfarctionFAERS: 1US FAERS
630Pulmonary congestionFAERS: 1US FAERS
631Pulmonary toxicityFAERS: 1US FAERS
632PurpuraFAERS: 1US FAERS
633QRS axis abnormalFAERS: 1US FAERS
634Reaction to azo-dyesFAERS: 1US FAERS
635RegurgitationFAERS: 1US FAERS
636Renal Cell CarcinomaFAERS: 1US FAERS
637Renal painFAERS: 1US FAERS
638Respiratory distressFAERS: 1US FAERS
639Respiratory tract congestionFAERS: 1US FAERS
640Restrictive cardiomyopathyFAERS: 1US FAERS
641Retinitis PigmentosaFAERS: 1US FAERS
642Reversible cerebral vasoconstriction syndromeFAERS: 1US FAERS
643Rheumatic FeverFAERS: 1US FAERS
644Rheumatic disorderFAERS: 1US FAERS
645Rheumatoid ArthritisFAERS: 1US FAERS
646RhinitisFAERS: 1US FAERS
647Right Ventricular DysfunctionFAERS: 1US FAERS
648ScabFAERS: 1US FAERS
649Seizure like phenomenaFAERS: 1US FAERS
650Self MutilationFAERS: 1US FAERS
651SemenuriaFAERS: 1US FAERS
652Sensory processing disorderFAERS: 1US FAERS
653Serotonin SyndromeFAERS: 1US FAERS
654Sinus ArrhythmiaFAERS: 1US FAERS
655Skin irritationFAERS: 1US FAERS
656Skin reactionFAERS: 1US FAERS
657SoliloquyFAERS: 1US FAERS
658SomnambulismFAERS: 1US FAERS
659Spermatozoa abnormalFAERS: 1US FAERS
660Spinal fusion surgeryFAERS: 1US FAERS
661Splenic vein thrombosisFAERS: 1US FAERS
662Status EpilepticusFAERS: 1US FAERS
663StillbirthFAERS: 1US FAERS
664StomatitisFAERS: 1US FAERS
665StubbornnessFAERS: 1US FAERS
666Subcutaneous AbscessFAERS: 1US FAERS
667Sudden Visual LossFAERS: 1US FAERS
668Sudden infant death syndromeFAERS: 1US FAERS
669Suicide threatFAERS: 1US FAERS
670Supraventricular tachycardiaFAERS: 1US FAERS
671Temperature intoleranceFAERS: 1US FAERS
672TeratomaFAERS: 1US FAERS
673Therapeutic product contaminationFAERS: 1US FAERS
674Therapeutic product effect decreasedFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
675Therapeutic product ineffectiveFAERS: 1US FAERS
676Therapeutic response delayedFAERS: 1US FAERS
677Therapy cessationFAERS: 1US FAERS
678Therapy non-responderFAERS: 1US FAERS
679Therapy regimen changedFAERS: 1US FAERS
680Thrombocytopenic purpuraFAERS: 1US FAERS
681Tongue bitingFAERS: 1US FAERS
682Tooth ErosionFAERS: 1US FAERS
683Tooth ExtractionFAERS: 1US FAERS
684Tooth LossFAERS: 1US FAERS
685ToothacheFAERS: 1US FAERS
686Traumatic Brain InjuryFAERS: 1US FAERS
687Trigeminal NeuralgiaFAERS: 1US FAERS
688Tympanic Membrane PerforationFAERS: 1US FAERS
689Urinary Tract PainFAERS: 1US FAERS
690Urinary sediment presentFAERS: 1US FAERS
691Urinary tract obstructionFAERS: 1US FAERS
692Urine output increasedFAERS: 1US FAERS
693Uterine RuptureFAERS: 1US FAERS
694Vaginal DischargeFAERS: 1US FAERS
695VasculitisFAERS: 1US FAERS
696Ventricular hypertrophyFAERS: 1US FAERS
697Ventricular hypokinesiaFAERS: 1US FAERS
698Ventricular parasystoleFAERS: 1US FAERS
699VerbigerationFAERS: 1US FAERS
700Visual brightnessFAERS: 1US FAERS
701Vulvovaginal discomfortFAERS: 1US FAERS
702Vulvovaginal pruritusFAERS: 1US FAERS
703Wolff-Parkinson-White SyndromeFAERS: 1US FAERS
704Wrong drug administeredFAERS: 1US FAERS
705X-ray limb abnormalFAERS: 1US FAERS
706YawningFAERS: 1US FAERS
707furuncleFAERS: 1US FAERS
708muscle injuryFAERS: 1US FAERS
709Adjustment disorder with depressed moodCanada Vigilance: 1Canada Vigilance
710FlatulenceCanada Vigilance: 1Canada Vigilance
711Product complaintCanada Vigilance: 3Canada Vigilance
712Sudden onset of sleepCanada Vigilance: 1Canada Vigilance
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120295

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.